These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Medical Management of Gastroenteropancreatic Neuroendocrine Tumors. Chandrasekharan C Surg Oncol Clin N Am; 2020 Apr; 29(2):293-316. PubMed ID: 32151362 [TBL] [Abstract][Full Text] [Related]
5. Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives. Appetecchia M; Baldelli R J Exp Clin Cancer Res; 2010 Mar; 29(1):19. PubMed ID: 20196864 [TBL] [Abstract][Full Text] [Related]
7. The management of gastroenteropancreatic neuroendocrine tumors with somatostatin analogues. Khagi S; Saif MW JOP; 2014 Jul; 15(4):295-8. PubMed ID: 25076324 [TBL] [Abstract][Full Text] [Related]
8. Escalated-dose somatostatin analogues for antiproliferative effect in GEPNETS: a systematic review. Chan DL; Ferone D; Albertelli M; Pavlakis N; Segelov E; Singh S Endocrine; 2017 Sep; 57(3):366-375. PubMed ID: 28726183 [TBL] [Abstract][Full Text] [Related]
9. Advances in the systemic treatment of pancreatic neuroendocrine tumors. Yalcin S Cancer Treat Rev; 2011 Apr; 37(2):127-32. PubMed ID: 20705397 [TBL] [Abstract][Full Text] [Related]
10. Advances in the treatment of gastroenteropancreatic neuroendocrine tumors. Phan AT Clin Adv Hematol Oncol; 2014 Dec; 12(12 Suppl 19):3-5. PubMed ID: 25768101 [No Abstract] [Full Text] [Related]
12. New pharmacologic therapies for gastroenteropancreatic neuroendocrine tumors. Lawrence B; Gustafsson BI; Kidd M; Modlin I Gastroenterol Clin North Am; 2010 Sep; 39(3):615-28. PubMed ID: 20951920 [TBL] [Abstract][Full Text] [Related]
13. Budget Impact of Somatostatin Analogs (SSAs) as Treatment for Metastatic Gastroenteropancreatic Neuroendocrine Tumors (mGEP-NETs) in US Hospitals. Clin Adv Hematol Oncol; 2016 May; 14(5 Suppl 7):10-1. PubMed ID: 27168105 [No Abstract] [Full Text] [Related]
14. Therapeutic and palliative options for diffuse neuroendocrine metastatic disease. Holen K J Gastrointest Surg; 2006 Mar; 10(3):337-40. PubMed ID: 16622986 [No Abstract] [Full Text] [Related]